N.Y.S. Psychiatric Institute IRBFebruary 2, 2023

FDA 483 - N.Y.S. Psychiatric Institute IRB - February 02, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore N.Y.S. Psychiatric Institute IRB

Record Details

The N.Y.S. Psychiatric Institute IRB in New York, NY, was cited for multiple deficiencies related to its oversight of human subject research. Observations included failures to report serious noncompliance and unanticipated problems, inadequate informed consent documents, improper use of expedited review, and issues with IRB meeting quorum and composition. These findings indicate significant deviations from regulatory requirements for institutional review boards.

Company: N.Y.S. Psychiatric Institute IRB
Inspection Date: February 2, 2023
Product Type: Drugs
Office: Division of Human and Animal Food Operations - East I
Person: Omadevi Somai

Open in Dashboard

ID · 9ee0a8d2-9e18-40d5-9593-3bb476ed7a23